Clinical Trials
Phase I Studies
RP5063 phase 1B in stable schizophrenia patients — completed
RP5063 phase 1A study in healthy subjects — completed
Phase II Studies
RP5063 phase II study in schizophrenia and schizoaffective disorder patients– completed
Phase III Studies
RP5063 phase III study in acute schizophrenia patients — in preparation
RP5063 phase III study in stable (maintenance phase) schizophrenia patients — in preparation